Treat-to-target in systemic lupus erythematosus: advancing towards its implementation
AR Parra Sánchez, AE Voskuyl… - Nature reviews …, 2022 - nature.com
The treat-to-target (T2T) concept has improved outcomes for patients with diabetes,
hypertension and rheumatoid arthritis. This therapeutic strategy involves choosing a well …
hypertension and rheumatoid arthritis. This therapeutic strategy involves choosing a well …
Machine learning techniques for personalised medicine approaches in immune-mediated chronic inflammatory diseases: applications and challenges
In the past decade, the emergence of machine learning (ML) applications has led to
significant advances towards implementation of personalised medicine approaches for …
significant advances towards implementation of personalised medicine approaches for …
Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus …
MF Ugarte-Gil, D Wojdyla, GJ Pons-Estel… - Annals of the …, 2017 - ard.bmj.com
Objective To evaluate disease activity statuses'(DAS') impact on systemic lupus
erythematosus (SLE) outcomes. Materials and methods Four DAS were defined: remission …
erythematosus (SLE) outcomes. Materials and methods Four DAS were defined: remission …
The frequency and outcome of lupus nephritis: results from an international inception cohort study
JG Hanly, AG O'Keeffe, L Su, MB Urowitz… - …, 2016 - academic.oup.com
Objective. To determine nephritis outcomes in a prospective multi-ethnic/racial SLE
inception cohort. Methods. Patients in the Systemic Lupus International Collaborating Clinics …
inception cohort. Methods. Patients in the Systemic Lupus International Collaborating Clinics …
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
M Petri, AM Orbai, GS Alarcón, C Gordon… - Arthritis & …, 2012 - Wiley Online Library
Abstract Objective The Systemic Lupus International Collaborating Clinics (SLICC) group
revised and validated the American College of Rheumatology (ACR) systemic lupus …
revised and validated the American College of Rheumatology (ACR) systemic lupus …
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
R Van Vollenhoven, A Voskuyl, G Bertsias… - Annals of the …, 2017 - ard.bmj.com
Objectives Treat-to-target recommendations have identified 'remission'as a target in
systemic lupus erythematosus (SLE), but recognise that there is no universally accepted …
systemic lupus erythematosus (SLE), but recognise that there is no universally accepted …
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
C Gordon, MB Amissah-Arthur, M Gayed… - …, 2018 - academic.oup.com
Caroline Gordon1, 2, 3, Maame-Boatemaa Amissah-Arthur1, Mary Gayed1, 3, Sue Brown4,
Ian N. Bruce5, 6, David D'Cruz7, Benjamin Empson8, Bridget Griffiths9, David Jayne10, 11 …
Ian N. Bruce5, 6, David D'Cruz7, Benjamin Empson8, Bridget Griffiths9, David Jayne10, 11 …
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
The principle of treating-to-target has been successfully applied to many diseases outside
rheumatology and more recently to rheumatoid arthritis. Identifying appropriate therapeutic …
rheumatology and more recently to rheumatoid arthritis. Identifying appropriate therapeutic …
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) …
Background and aims We studied damage accrual and factors determining development
and progression of damage in an international cohort of systemic lupus erythematosus …
and progression of damage in an international cohort of systemic lupus erythematosus …
[HTML][HTML] The diagnosis and treatment of systemic lupus erythematosus
A Kuhn, G Bonsmann, HJ Anders, P Herzer… - Deutsches Ärzteblatt …, 2015 - ncbi.nlm.nih.gov
Background Systemic lupus erythematosus (SLE) is an autoimmune disease with a
prevalence of 36.7/100 000 in Germany and a female/male ratio of 4: 1. The clinical course …
prevalence of 36.7/100 000 in Germany and a female/male ratio of 4: 1. The clinical course …